Jun 15, 2023 / 05:00PM GMT
David Apelian - Eiger BioPharmaceuticals, Inc. - Interim CEO & Director
Good afternoon. My name is David Apelian, and I am the Interim Chief Executive Officer and Member of the Board of Eiger BioPharmaceuticals. I'm very happy to welcome you to the Eiger BioPharmaceuticals 2023 annual stockholders' meeting, and I will act as the Chair of this meeting.
The meeting will now officially come to order. The time is now 1:00 PM. Eastern Time on Thursday, June 15, 2023, and the polls are now open for voting on all matters to be presented. As you know, we're hosting today's meeting through a virtual online platform hosted by Broadridge. This meeting is being recorded and will be archived for one year after the date of the annual meeting at www.virtualshareholdermeeting.com/EIGR2023.
Before we proceed with the formal business of the meeting, I'd like to introduce to you the current members of the Board who are with us virtually today. Thomas Dietz, Chairman of the Board; Christine Murray; Jeffrey Glenn;
Eiger BioPharmaceuticals Inc Annual Shareholders Meeting Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers